Steroids in pediatric eosinophilic esophagitis

Area of Science:

• Pediatric Gastroenterology
• Pharmacology
• Immunology

Background:

• Eosinophilic esophagitis (EoE) is a chronic inflammatory condition in children.
• Topical corticosteroids are a primary treatment for pediatric EoE.
• Understanding optimal corticosteroid use is crucial for managing this condition.

Purpose of the Study:

• To review the efficacy and safety of swallowed fluticasone and oral budesonide for pediatric EoE.
• To explore emerging corticosteroid therapies and delivery systems for EoE.
• To identify current knowledge gaps and future research directions in pediatric EoE corticosteroid treatment.

Main Methods:

• Literature review of studies on swallowed fluticasone and oral budesonide in children with EoE.
• Analysis of data on side effect profiles, including Cushing syndrome.
• Evaluation of emerging research on alternative corticosteroids (e.g., ciclesonide) and delivery methods.

Main Results:

• Swallowed fluticasone and oral viscous budesonide demonstrate effectiveness as first-line EoE therapies in children.
• Treatment with these agents shows minimal side effects, with no evidence of Cushing syndrome.
• Newer studies on alternative delivery systems and corticosteroids like ciclesonide are promising.

Conclusions:

• Topical corticosteroids remain a cornerstone of pediatric EoE management.
• Further research is needed to optimize corticosteroid dosage, delivery, and long-term safety profiles.
• Investigating maintenance therapies and novel agents is essential for advancing EoE treatment.